US EditionIntroducing a new CME text module, Advancing IBD Management with Precision Medicine and Emerging Data
Summary by American Gastroenterological Association
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Introducing a new CME text module, Advancing IBD Management with Precision Medicine and Emerging Data
AGA, in proud partnership with Clinical Care Options, LLC, and with support from an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA, invites you to explore the latest in inflammatory bowel disease (IBD) care through the innovative text module: Advancing Inflammatory Bowel Disease Management with Precision Medicine and Emerging DataThis dynamic educational activity is designed for gastroenterology professionals, including ph…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
